Neither mycophenolate acyl-glucuronide levels nor their areas under the curve are responsible for the gastrointestinal side effects in kidney transplant recipients receiving EC-MPA: A prospective trial

Transplantation Proceedings

Volumn 42, Issue 10, 2010, Pages 4049-4052

  Raggi, M C ^a   Siebert, S B ^a   Abendroth, D K ^b   Steimer, W ^a   Friess, H ^a   Thorban, S G ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MYCOPHENOLATE ACYL GLUCURONIDE; MYCOPHENOLIC ACID; UNCLASSIFIED DRUG;

AREA UNDER THE CURVE; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL TRIAL; CONFERENCE PAPER; DRUG ABSORPTION; GASTROINTESTINAL TOXICITY; GRAFT RECIPIENT; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; METABOLITE; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; SCORING SYSTEM; STATISTICAL ANALYSIS; TREATMENT RESPONSE; VIRUS INFECTION;

AREA UNDER CURVE; GASTROINTESTINAL TRACT; GLUCURONIDES; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MYCOPHENOLIC ACID; PATIENT SATISFACTION; PROSPECTIVE STUDIES; QUESTIONNAIRES;

EID: 78650458912     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.09.029     Document Type: Conference Paper

References (17)

1. E. Schtz, M. Shipkova, and V.W. Armstrong Identification of a pharmacologically active metabolite of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil Clin Chem 45 1999 419
2. M. Naesens, D.R. Kuypers, and F. Streit Rifampin induces alterations in mycophenolic acid glucuronidation and elimination: implications for drug exposure in renal allograft recipients Clin Pharmacol Ther 80 2006 509
3. H. Müller, S. Solari, and C. Zuniga Therapeutic drug monitoring of mycophenolic acid in kidney transplant patients: a abbreviated sampling strategy Transplant Proc 39 2007 596
4. E. Eypasch, J.I. Williams, and S. Wood-Dauphinee Gastrointestinal Quality of Life Index: development, validation and application of a new instrument Br J Surg 82 1995 216
5. D.A. Revicki, M. Wood, and I. Wiklund Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease Qual Life Res 7 1998 75
6. Fahrenberg J: Die Freiburger Beschwerdenliste FBL: Zeitschrift für Klinische Psychologie; 4:79, 1975
7. J. Schumacher, W. Laubach, and E. Brhler Wie zufrieden sind wir mit unserem Leben? Soziodemographische und psychologische Prdiktoren der allgemeinen und bereichsspezifischen Lebenszufriedenheit Zeitschrift fr Medizinische Psychologie 4 1995 17
8. L.S. Ting, N. Partovi, and R.D. Levy Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and ACY1 glucuronide metabolites in stable thoracic transplant recipients Ther Drug Monit 30 3 2008 282
9. N.M. Davies, J. Griny, and R. Heading Gastrointestinal side effects of mycophenolic acid in renal transplant patients: a reappraisal Nephrol Dial Transplant 22 2007 2440
10. E. Wieland, M. Shipkova, and U. Schellhaas Induction of cytokine release by the acyl glucuronide of mycophenolic acid: a link to side effects? Clin Biochem 33 2000 107
11. B. Lin, Y.C. Zhu, and Y.P. Lu Correlation of mycophenolic acid pharmacokinetic parameters with clinical events in kidney transplant patients treated with mycophenolate mofetil Zhonghua Yi Xue Za Zhi 89 2009 251
12. M. Mourad, J. Malaise, and D. Chaib Eddour Correlation of mycophenolic acid pharmacokinetic parameters with side effects in kidney transplant patients treated with mycophenolate mofetil Clin Chem 47 2001 88
13. M. Naesens, H. de Loor, and Y. Vanrenterghem The impact of renal allograft function on exposure and elimination of mycophenolic acid (MPA) and its metabolite MPA 7-O-glucuronide Transplantation 84 2007 362
14. S. Payen, D. Zhang, and A. Maisin Population pharmacokinetics of mycophenolic acid in kidney transplant pediatric and adolescent patients Ther Drug Monit 27 2005 378
15. E. Lévesque, M.O. Benoit-Biancamano, and R. Delage Pharmacokinetics of mycophenolate mofetil and its glucuronide metabolites in healthy volunteers Pharmacogenomics 9 2008 869
16. M. Oremus, J. Zeidler, and M.H.H. Ensom Utility of Monitoring Mycophenolic Acid in Solid Organ Transplant Patients Evidence Report/Technology Assessment No. 164. AHRQ Publication No. 08-E006 2008 Agency for Healthcare Research and Quality Rockville, MD
17. E. Wieland, M. Shipkova, and U. Schellhaas Induction of cytokine release by the acyl glucuronide of mycophenolic acid: a link to side effects? Clin Biochem 33 2000 107